Comparative study of the effects of vitamin C and bleomycin on smokers' and non-smokers' lymphocytes in clastogenicity assays.
Free radicals are products of metabolic reactions and of external factors that can injure different biological molecules. However, different antioxidant agents can prevent the action of these reactive species and the damage they cause. Vitamin C (VC) is an important micronutrient found in the diet, which presents defense mechanisms against the free radicals that challenge the cells of the organism. The objective of the present study was to investigate the effect of VC as a modulator of the damage induced in DNA by bleomycin (BLM) in lymphocytes from smokers and non-smokers. The difference in response to the mutagenic potential of BLM between smokers and non-smokers was also investigated. Peripheral blood lymphocyte cultures were treated simultaneously with BLM (20 microg/ml) and/or VC (100, 200, and 400 microg/ml) in the G2 phase of the cell cycle. The results obtained did not demonstrate a statistically significant difference in the response to the antitumor agent BLM between smokers and non-smokers. The data also showed that VC had no significant modulating effect on the frequency of chromosome aberrations induced by BLM in the cells of smokers and non-smokers under the experimental conditions used.
D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology*; D000975:Antioxidants / Q000494:pharmacology*; D001205:Ascorbic Acid / Q000494:pharmacology*; D001761:Bleomycin / Q000633:toxicity*; D002453:Cell Cycle; D002869:Chromosome Aberrations; D003069:Coffee / Q000378:metabolism; D005260:Female; D006801:Humans; D008214:Lymphocytes / Q000648:ultrastructure*; D008297:Male; D009152:Mutagenicity Tests; D009153:Mutagens / Q000494:pharmacology; D012907:Smoking